EXAS

ONCOTYPE DX OY3

TASK ORDER IN SUPPORT OF OY1 - STL VAMC ONCOTYPE-DX TESTING SERVICES AWARD

TASK ORDER IN SUPPORT OF OY 1 - TOPEKA VAMC ONCOTYPE-DX TESTING SERVICES AWARD

TASK ORDER IN SUPPORT OF OY 1 - LEAVENWORTH VAMC ONCOTYPE-DX TESTING SERVICES AWARD

HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R. 7118 support Genomic Answers for Childrens Health Act Support colorectal cancer screening prevention standards Support patient access to cancer screening and diagnostics Support veteran access to guideline-recommended colorectal cancer screening

Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related to cancer screenings Expanding access to cancer screening

H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.7118 Genomic Answers for Children's Health Act H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.7118 Genomic Answers for Children's Health Act FY27 MilCon-VA appropriations Access to colorectal cancer screening tests

HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. Support colorectal cancer screening standards Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 7714 Colorectal Cancer Early Detection Act Support S 1717 Ensuring Patient Access to Critical Breakthrough Products Act Support veteran access to guideline-recommended colorectal cancer screening.

Medicare Multi-Cancer Early Detection Screening Coverage Act

H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests

Support veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months. Support patient access to cancer screening and diagnostics. Support HR 1780/S 642 Finn Sawyer Access to Cancer Testing Act Support S 1410 Find It Early Act Support HR 2921/S 2745 Federal Firefighter Cancer Detection and Prevention Act of 2025 Support HR 1610 FIRE Cancer Act Support HR 4752/S 2760 Reducing Hereditary Cancer Act Support HR 771

Medicare Multi-Cancer Early Detection Screening Coverage Act H.R.842: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act S.339: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Expanding access to cancer screening

H.R. 842, S.339 The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act Issues related FDA regulation of laboratory tests H.R. 842, S.339 the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act FY26 MilCon-VA appropriations Access to colorectal cancer screening tests

Support legislative efforts to develop alternative diagnostics legislation in lieu of LDT rule. Support veteran access to guideline-recommended colorectal cancer screening. HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act: This bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months.